Science News | Autism Speaks

Arbaclofen Shows Promise for Treating Core Symptoms of Autism

Compound advances into larger clinical trials; could pave the way for other future medicines as well

Researchers produce autism behaviors in mice by mimicking infection during pregnancy; reverse symptoms by resetting offspring’s immune system

... More...

CDC Revises Estimate of Autism Prevalence: 1 in 88

Continuing increase in prevalence reaffirms public-health crisis

... More...

Hundreds of Tiny Mutations Linked to Autism

Many arise spontaneously in germ cells; may explain why autism risk higher among children of older fathers

... More...

Discovery of Pre-symptom Marker of Autism

Researchers use MRI to reveal differences in the brain’s white matter in infants as young as 6 months

... More...

Deeper Understanding of Link between Chemical Pollutants and Autism

The year brought advances in understanding whether and how chemical pollutants affect brain development in ways that may predispose to autism

... More...

Field Trials Suggest New Criteria for Diagnosing Autism 'Reliable'

American Psychiatric Association approves DSM-5 changes; autism advocates call for further study

... More...

Peer Training Outperforms Traditional Autism Interventions

Training classmates produces greater gains in social inclusion than even one-on-one training between therapist and child

... More...

Autism Speaks Funds First DELSIA Award

... More...

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to ... More...